Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 5 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 10/5 APOTEX perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 10/5 apotex perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-PERINDOPRIL/AMLODIPINE TABLET Kanāda - angļu - Health Canada

apo-perindopril/amlodipine tablet

apotex inc - perindopril arginine; amlodipine (amlodipine besylate) - tablet - 7mg; 5mg - perindopril arginine 7mg; amlodipine (amlodipine besylate) 5mg - angiotensin-converting enzyme inhibitors

APO-PERINDOPRIL/AMLODIPINE TABLET Kanāda - angļu - Health Canada

apo-perindopril/amlodipine tablet

apotex inc - perindopril arginine; amlodipine (amlodipine besylate) - tablet - 14mg; 10mg - perindopril arginine 14mg; amlodipine (amlodipine besylate) 10mg - angiotensin-converting enzyme inhibitors

PRESTALIA- perindopril arginine, amlodipine besylate tablet Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

prestalia- perindopril arginine, amlodipine besylate tablet

marina biotech - perindopril arginine (unii: tft5im1kgb) (perindoprilat - unii:2uv6znq92k), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - perindopril arginine 3.5 mg - prestalia contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, and is indicated for the treatment of hypertension, to lower blood pressure. prestalia may be used in patients whose blood pressure is not adequately controlled on monotherapy. prestalia may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including amlodipine and the ace inhibitor class to which perindopril principally belongs. there are no controlled trials demonstrating risk reduction with prestalia. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithr

REAPTAN 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

reaptan 10/10 perindopril arginine 10mg/ amlodipine (as besilate) 10mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose - is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

COVERAM 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg uncoated tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

coveram 10/5 perindopril arginine 10mg/ amlodipine (as besilate) 5mg uncoated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - coveram is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

CHEMMART Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

chemmart perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

GenRx Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

genrx perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.